Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00545220 · ClinicalTrials.gov registry record · NA
Problem Solving Training and Low Vision Rehabilitation
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 430
- Enrollment target
NCT00545220 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 430 participants.
The verdict
NCT00545220, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 430 participants
- Enrollment target
Study Summary
Vision loss can result in feelings of frustration, helplessness, anxiety, depression, and anger, which compromise a person's activities of everyday living. While emotional distress may resolve in some persons without intervention, unmanaged and persistent distress places the person at risk for continued decrements in health status and the potential development of more severe conditions (i.e., depression, poor health outcomes). Persons with low vision will be recruited and randomly assigned to either an innovative, problem-solving training (PST) intervention group designed specifically for persons with low vision or a sham intervention/control group. Primary and secondary outcomes will be assessed at baseline prior to intervention and at 3 month follow-up, 7 month follow-up, 12 month follow-up, and 24 month follow-up by a research interviewer masked to participants' randomization. This project will: (1) demonstrate how specified physical and emotional outcomes of persons with low vision change across time, (2) evaluate the effectiveness of a PST intervention that will be delivered to persons with low vision; and (3) identify persons with low vision who are at risk for adverse emotional and health outcomes.
Interventions
- BEHAVIORAL problem-solving training
- BEHAVIORAL sham intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2007-10 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00545220
The ClinicalTrials.gov registry entry for NCT00545220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 430 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which problem-solving training is the first listed.
NCT00545220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00545220 about?
NCT00545220 is a clinical study titled "Problem Solving Training and Low Vision Rehabilitation". Vision loss can result in feelings of frustration, helplessness, anxiety, depression, and anger, which compromise a person's activities of everyday living. While emotional distress may resolve in some persons without intervention, unmanaged and persistent distress places the person at risk for conti...
What is the current status of trial NCT00545220?
This trial is currently completed. It is a NA study. The enrollment target is 430 participants. The study started on 2007-10. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00545220?
The interventions under investigation include: problem-solving training (BEHAVIORAL), sham intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00545220?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.